Fill/finish capacity isn't the real constraint

Preview text: Fill/finish capacity isn't the real constraint 96 Combination products, GLP-1 slots, and…

Tuesday, Apr 21, 2026 at 6:31 AM EasternHubSpot

PharmaSourceFill/finish capacity isn't the real constraint

Image not available

No image available for this email.

Subject: Fill/finish capacity isn't the real constraint
Preview text: Fill/finish capacity isn't the real constraint 96 Combination products, GLP-1 slots, and…
From: news@pharmasource.global
Brand: PharmaSource
ESP: HubSpot
Sent: Tue Apr 21, 2026, 6:31 AM ET
Size: 75 KB
Images: 10
Links: 36, 2 of them buttons
Subject length: 46 characters

Against PharmaSource's usual

Sent in the 6 AM hour, which holds 8% of its emails; 33% arrive in the 2 AM hour. The subject is 46 characters; its average is 45.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

from news.pharmasource.global [172.246.37.169] by our receiving server with ESMTPS

Other sending headers (names only): X-Csa-Complaints, X-Mailin-Campaign, X-Mailin-Client, X-sib-id

	May 14, 2026 5:00 AM	Makary resigns. Who's running the FDA now?
	May 4, 2026 5:00 PM	8 challenges defining pharma outsourcing in 2026
	Apr 27, 2026 5:00 PM	AI, vibe coding and pharma manufacturing
	Apr 21, 2026 6:31 AM	Fill/finish capacity isn't the real constraint (this email)
	Apr 14, 2026 1:30 AM	Pharma's DTC shift is breaking the supply chain
	Apr 10, 2026 1:30 AM	The 100% pharma tariff that isn't
	Mar 31, 2026 2:00 AM	DCAT Week 2026: $859 disclosed investments mapped